Hla-a24- or hla-a2-binding peptide of parathyroid...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 39/00 (2006.01) A61P 19/00 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) C07K 14/47 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2567942

A cancer antigen peptide which is a peptide fragment originating in a parathyroid hormone-related protein, can bind to HLA-A24 or HLA-A2 antigen and can be recognized by cytotoxic T lymphocytes or its derivative being equivalent thereto in functional properties is useful in treating and preventing prostatic cancer.

Un peptide d'antigène du cancer, qui est un fragment de peptide provenant d'une protéine liée à la parathormone, il peut se lier à un antigène HLA-A24 ou HLA-A2 et être reconnu par les lymphocytes T cytotoxiques, son dérivé équivalent en propriétés fonctionnelles est utile pour traiter et éviter le cancer de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hla-a24- or hla-a2-binding peptide of parathyroid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hla-a24- or hla-a2-binding peptide of parathyroid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hla-a24- or hla-a2-binding peptide of parathyroid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1943659

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.